Radioimmunterapi mot HER-2-positiv bryst- og eggstokkreft
نویسندگان
چکیده
منابع مشابه
Probing DNA by 2-OG-Dependent Dioxygenase
TET-mediated 5-methyl cytosine (5mC) oxidation acts in epigenetic regulation, stem cell development, and cancer. Hu et al. now determine the crystal structure of the TET2 catalytic domain bound to DNA, shedding light on 5mC-DNA substrate recognition and the catalytic mechanism of 5mC oxidation.
متن کاملPreclinical HER-2 Vaccines: From Rodent to Human HER-2
Effective prevention of human cancer with vaccines against viruses, such as HBV and HPV, raises the question whether also non-virus related tumors could be prevented with immunological means. Studies in HER-2-transgenic mice showed that powerful anti-HER-2 vaccines, could almost completely prevent the onset of mammary carcinoma. Protective immune responses were orchestrated by T cells and their...
متن کاملSerum-albumin and risk of thyroid cancer: A population-based, matched case-control study
Flere epidemiologiske undersøkelser fra 1980og 1990-årene har funnet en invers assosiasjon mellom salbuminnivået og sykelighet/dødelighet av kreft. I utforskningen av skjoldkjertelkreftens etiologi og patogenese ble det derfor ansett som viktig å finne og bestemme styrken av en slik sammenheng når det gjelder skjoldkjertelkreft. Derfor ble alle med tilstrekkelig mengde serum deponert i Janusban...
متن کاملExpression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers.
A significant number of HER-2 amplified breast cancers is effectively treated by trastuzumab and further shows receptor-enhanced chemosensitivity. Recent studies have postulated transactivation of HER-2 also in tumors expressing phosphorylated/activated HER-2 (pHER-2) and of the HER-3/HER-4 ligand heregulin (HRG), independent of HER-2 amplification. As a consequence, a subset of tumors without ...
متن کاملHER-3 expression in HER-2-amplified breast carcinoma
AIM OF THE STUDY To determine whether the expression of HER-3 influences the survival of HER-2 positive patients with breast cancer (BC). MATERIAL AND METHODS In the present work, the expression of HER-3 in a group of 35 HER-2 positive patients with BC was studied by performing immunohistochemistry (IHC) in formalin-fixed paraffin embedded tissues. RESULTS Higher HER-3 status if estimated b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Tidsskrift for Den norske legeforening
سال: 2013
ISSN: 0029-2001
DOI: 10.4045/tidsskr.13.0503